Oogenesin 4 inhibitors belong to a chemical class that targets the oogenesin family of proteins, specifically oogenesin 4, a protein thought to be involved in early developmental processes and cellular differentiation. Oogenesins are predominantly expressed in oocytes, the cells that give rise to eggs in the reproductive cycle, and their role appears to be intricately connected to the regulation of gene expression during early embryogenesis. Oogenesin 4, like its related isoforms, is believed to influence transcriptional activity and may have structural properties that affect chromatin organization. Inhibitors of oogenesin 4 disrupt these processes by interfering with the molecular interactions or signaling pathways associated with this protein, thereby influencing cellular dynamics at a fundamental level.
The design of oogenesin 4 inhibitors often focuses on modulating the conformational state of the oogenesin protein, either by small molecules or peptides that bind to its active sites, or by affecting post-translational modifications that are necessary for its function. Structural biology techniques, such as X-ray crystallography or cryo-electron microscopy, have been employed to determine the precise binding modes of these inhibitors, offering insights into the structural requirements for effective inhibition. The inhibition of oogenesin 4 could have significant implications for understanding oocyte development, fertilization, and early cell lineage specification, making it a critical area of study in developmental biology and molecular embryology. Such inhibitors provide a valuable tool for probing the biochemical pathways in which oogenesins participate, shedding light on the fundamental mechanisms of cellular differentiation and genomic regulation during the earliest stages of life.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG-132 is a proteasome inhibitor that can indirectly affect Oog4 by inhibiting the degradation of ubiquitin-tagged substrates, potentially influencing the ubiquitin ligase-substrate adaptor activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib is a proteasome inhibitor. Similar to MG-132, it can indirectly affect Oog4 by inhibiting the proteasome and altering the degradation of ubiquitin-tagged substrates. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $207.00 | 8 | |
BEZ235 inhibits NEDD8-activating enzyme, leading to the inactivation of cullin-RING ligases (CRLs). Oog4, as part of the Cul2-RING ubiquitin ligase complex, may be indirectly affected by CRL inhibition. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin hydrochloride is an anthracycline antibiotic that can induce apoptosis in various cell types. If Oog4 is involved in apoptosis regulation, Doxorubicin may indirectly affect its function by promoting cell death. | ||||||
(–)-Nutlin-3 | 675576-98-4 | sc-222086 sc-222086A | 1 mg 5 mg | $120.00 $215.00 | 2 | |
Nutlin-3 disrupts the interaction between p53 and MDM2, leading to increased p53 levels. Elevated p53 can influence the ubiquitin ligase-substrate adaptor activity of Oog4. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a phosphoinositide 3-kinase (PI3K) inhibitor. PI3K/AKT signaling can impact protein degradation and ubiquitination. Inhibition of PI3K may indirectly affect Oog4's functions. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D is an RNA synthesis inhibitor. It can affect transcription, including negative regulation, which may impact Oog4's functions in transcriptional regulation. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide is a protein synthesis inhibitor. It can influence the synthesis of proteins involved in ubiquitination processes, potentially impacting Oog4's function as a substrate adaptor. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR signaling, which is involved in protein synthesis and ubiquitination. Inhibition of mTOR by Rapamycin may indirectly impact Oog4's function in protein ubiquitination. | ||||||